| |
| |
|
| Insider
Information: |
Barer Sol J |
| Relationship: |
Director |
| City: |
Warren |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
5,895,217 |
|
|
Indirect Shares
|
2,793,946 |
|
|
| Direct
Value |
$81,973,919 |
|
|
|
Indirect Value
|
$6,974,534 |
|
|
| Total
Shares |
8,689,163 |
|
|
| Total
Value |
$88,948,453 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Celgene Corp |
CELG |
Director |
2011-01-13 |
692,192 |
2011-01-13 |
61,281 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
Director |
2013-03-15 |
45,000 |
2009-11-04 |
0 |
Premium* |
|
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
Director |
2016-11-29 |
0 |
2011-05-05 |
0 |
Premium* |
|
|
Inspiremd, Inc |
NSPR |
Director |
2016-03-21 |
1,141,690 |
2016-03-21 |
170,000 |
Premium* |
|
|
Aevi Genomic Medicine Inc |
GNMX |
Director |
2019-12-05 |
0 |
2019-12-05 |
0 |
Premium* |
|
|
Cervomed Ord Shs |
CRVO |
Chairman of the Board,... |
2014-06-06 |
1,011,072 |
|
0 |
Premium* |
|
|
Contrafect Corp |
CFRX |
Director |
2017-07-25 |
815,933 |
|
0 |
Premium* |
|
|
PDS Biotechnology Corp |
PDSB |
Director |
2015-10-06 |
0 |
2019-03-15 |
678,075 |
Premium* |
|
|
Teva Pharmaceutical Industries L... |
TEVA |
Director |
2023-08-04 |
371,516 |
2018-09-03 |
0 |
Premium* |
|
|
Neximmune, Inc. |
NEXI |
Director |
2022-11-17 |
1,817,814 |
2022-11-17 |
1,884,590 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
122 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRVO |
Cervomed Ord Shs |
Chairman of the BoardOfficer |
• • • |
2013-11-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
45,833,333 |
|
- |
|
| CFRX |
Contrafect Corp |
Director |
– • – |
2014-07-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
775,933 |
|
- |
|
| NEXI |
Neximmune, Inc. |
Director |
– • – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
129,007 |
|
- |
|
| NEXI |
Neximmune, Inc. |
Director |
– • – |
2021-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
567,632 |
|
- |
|
| CELG |
Celgene Corp |
Chief Operating Officer |
• • – |
2004-03-01 |
5 |
GA |
$0.00 |
$0 |
I/I |
250,000 |
250,000 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Operating Officer |
• • – |
2004-03-01 |
5 |
GD |
$0.00 |
$0 |
D/D |
250,000 |
231,616 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Operating Officer |
• • – |
2005-03-29 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,500 |
346,133 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Operating Officer |
• • – |
2005-06-09 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,250 |
346,133 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Operating Officer |
• • – |
2005-09-07 |
4 |
D |
$0.00 |
$0 |
I/I |
(0) |
250,000 |
|
- |
|
| CELG |
Celgene Corp |
Chief Operating Officer |
• • – |
2005-12-28 |
5 |
GD |
$0.00 |
$0 |
D/D |
18,180 |
346,133 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Executive Officer |
• • – |
2006-07-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
16,080 |
1,194,638 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Executive Officer |
• • – |
2006-11-10 |
5 |
GD |
$0.00 |
$0 |
D/D |
20,884 |
1,194,638 |
0 |
- |
|
| CELG |
Celgene Corp |
Director |
– • – |
2010-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
59,144 |
658,858 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Director |
– • – |
2011-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
29,890 |
29,890 |
0 |
- |
|
| NSPR |
Inspiremd, Inc |
Director |
– • – |
2011-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,900,000 |
3,900,000 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
Director |
– • – |
2013-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
7,000 |
0 |
- |
|
| NSPR |
Inspiremd, Inc |
Director |
– • – |
2013-07-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
850,000 |
200,000 |
0 |
- |
|
| NSPR |
Inspiremd, Inc |
Director |
– • – |
2013-07-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
850,000 |
850,000 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
Director |
– • – |
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
119,000 |
0 |
- |
|
| NSPR |
Inspiremd, Inc |
Director |
– • – |
2015-03-09 |
4 |
B |
$0.00 |
$0 |
D/D |
2,500,000 |
2,942,308 |
2.31 |
- |
|
| PDSB |
PDS Biotechnology Corp |
Director |
– • – |
2015-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
587,810 |
587,810 |
0 |
- |
|
| NSPR |
Inspiremd, Inc |
Director |
– • – |
2016-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1 |
294,232 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Director |
– • – |
2016-11-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(29,890) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Director |
– • – |
2018-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,162 |
2,162 |
0 |
- |
|
| PDSB |
PDS Biotechnology Corp |
Director |
• • – |
2019-03-15 |
4 |
OE |
$0.00 |
$0 |
I/I |
20,000 |
678,075 |
0 |
- |
|
122 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
